Five of the world’s biggest drugs companies have agreed to slash the price of
their anti-HIV drugs in developing countries by 85 per cent following sustained
pressure from health agencies, Third World governments and patient groups
(Â鶹´«Ã½, 29 April, p 14).
One of the companies, Glaxo Wellcome, is
cutting the price of triple drug therapy from $16 to $2 a day. But
pressure groups have warned that even at these prices, poverty and a lack of
health infrastructure in poor countries will mean the benefits are limited.
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
We've found a mysterious substance on Titan and Pluto
2
Faecal transplant makes the brains of old mice act young again
3
A quantum state that lasts forever may finally be within our grasp
4
Autism may have two distinct subtypes that vary by brain activity
5
The secrets to keeping your brain sharp in old age
6
Has the answer to life's origins been hiding in our cells all along?
7
Pigeons lock their eyes in place when they are flying
8
Millions of fossil whale bones found in deep-ocean ‘necropolis’
9
Most portable air conditioners suck – but there's an easy fix
10
We may have finally solved cosmology's chicken-or-the-egg problem
